Literature DB >> 9222872

The role of oxidized LDL in the atherogenic process.

J L Witztum1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 9222872     DOI： 10.5551/jat1994.1.71

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  5 in total

Review 1.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

Review 2.  What combination therapy with a statin, if any, would you recommend?

Authors:  Carlos A Dujovne; Craig D Williams; Matthew K Ito
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

3.  Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.

Authors:  M Miyazaki; H Sakonjo; S Takai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

4.  Apolipoproteins and diabetic retinopathy.

Authors:  Alan Chait; Vince N Montes
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 5.  Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.

Authors:  Raelene J Pickering; Carlos J Rosado; Arpeeta Sharma; Shareefa Buksh; Mitchel Tate; Judy B de Haan
Journal:  Clin Transl Immunology       Date:  2018-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.